Mineralys Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Congleton Jon | Chief Executive Officer | Option Exercise | 24,082 | $0.54 | $13,004 | 655,387 | Nov 21, 2025 |
| Catalys Pacific Fund, LP | — | Sale | 1,000,000 | $43.35 | $43,350,000 | 7,903,838 | Nov 20, 2025 |
| Karydas Daphne | — | Option Exercise | 15,000 | $10.20 | $153,000 | 15,000 | Nov 13, 2025 |
| Levy Adam Scott | CFO and Secretary | Option Exercise | 6,613 | $15.44 | $102,105 | 138,920 | Nov 11, 2025 |
| Congleton Jon | Chief Executive Officer | Sale | 12,806 | $41.64 | $533,242 | 818,499 | Nov 11, 2025 |
| Gold Alexander M | — | Sale | 10,000 | $42.43 | $424,300 | 5,000 | Nov 11, 2025 |
| Rodman David Malcom | Chief Medical Officer | Sale | 10,369 | $43.01 | $445,971 | 71,155 | Oct 15, 2025 |
| Levy Adam Scott | CFO and Secretary | Sale | 3,392 | $42.26 | $143,346 | 116,865 | Oct 13, 2025 |
| Congleton Jon | Chief Executive Officer | Sale | 13,548 | $42.63 | $577,551 | 832,857 | Oct 13, 2025 |
| Rodman David Malcom | Chief Medical Officer | Sale | 2,065 | $36.47 | $75,311 | 81,524 | Sep 15, 2025 |
| AKKARAJU SRINIVAS | — | Purchase | 588,235 | $25.50 | $14,999,993 | 588,235 | Sep 4, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 1,176,470 | $25.50 | $29,999,985 | 5,456,521 | Sep 4, 2025 |
| Rodman David Malcom | Chief Medical Officer | Sale | 11,365 | $12.93 | $146,949 | 92,891 | Aug 12, 2025 |
| Levy Adam Scott | CFO and Secretary | Sale | 8,425 | $15.10 | $127,218 | 132,934 | Jul 30, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 109,273 | Jul 14, 2025 |
| Congleton Jon | Chief Executive Officer | Sale | 15,884 | $14.51 | $230,477 | 846,405 | Jul 11, 2025 |
| Levy Adam Scott | CFO and Secretary | Sale | 10,758 | $14.45 | $155,453 | 206,612 | Jul 11, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,348 | $1.08 | $6,856 | 113,017 | Jun 13, 2025 |
| Rodman David Malcom | Chief Medical Officer | Sale | 11,366 | $15.29 | $173,786 | 106,669 | May 14, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 118,035 | May 12, 2025 |
| Rodman David Malcom | Chief Medical Officer | Sale | 8,400 | $14.83 | $124,572 | 111,686 | Apr 14, 2025 |
| Levy Adam Scott | CFO and Secretary | Sale | 10,757 | $12.06 | $129,729 | 215,340 | Apr 11, 2025 |
| Congleton Jon | Chief Executive Officer | Sale | 15,319 | $12.19 | $186,739 | 862,289 | Apr 11, 2025 |
| Rodman David Malcom | Chief Medical Officer | Sale | 22,406 | $16.77 | $375,749 | 116,704 | Apr 1, 2025 |
| Samsara BioCapital, L.P. | — | Purchase | 600,000 | $13.50 | $8,100,000 | 5,674,916 | Mar 13, 2025 |
| AKKARAJU SRINIVAS | — | Purchase | 600,000 | $13.50 | $8,100,000 | 5,674,916 | Mar 13, 2025 |
| RA Capital Nexus Fund III, L.P. | — | Purchase | 1,296,296 | $13.50 | $17,499,996 | 4,280,051 | Mar 13, 2025 |
| Slingsby Brian Taylor | — | Purchase | 259,259 | $13.50 | $3,499,997 | 8,903,838 | Mar 13, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 170,869 | Mar 12, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,348 | $1.08 | $6,856 | 164,520 | Feb 12, 2025 |
| Levy Adam Scott | CFO and Secretary | Sale | 100 | $9.63 | $963 | 226,097 | Jan 13, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 158,172 | Jan 13, 2025 |
| Congleton Jon | Chief Executive Officer | Sale | 18,333 | $9.06 | $166,097 | 877,608 | Jan 13, 2025 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 5,017 | $0.54 | $2,709 | 146,008 | Dec 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 5,026 | $1.08 | $5,428 | 146,017 | Nov 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Sale | 25,482 | $15.03 | $382,994 | 135,974 | Nov 6, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 5,017 | $0.54 | $2,709 | 130,622 | Oct 14, 2024 |
| Levy Adam Scott | CFO and Secretary | Sale | 10,757 | $13.57 | $145,972 | 236,854 | Oct 11, 2024 |
| Congleton Jon | Chief Executive Officer | Sale | 15,271 | $13.52 | $206,464 | 895,941 | Oct 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 125,605 | Sep 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,348 | $1.08 | $6,856 | 114,238 | Aug 12, 2024 |
| Slingsby Brian Taylor | — | Sale | 550,000 | $13.05 | $7,177,500 | 8,644,579 | Jul 24, 2024 |
| Rodman David Malcom | Chief Medical Officer | Sale | 525 | $15.00 | $7,875 | 102,873 | Jul 16, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 102,873 | Jul 11, 2024 |
| Levy Adam Scott | CFO and Secretary | Sale | 10,757 | $13.14 | $141,347 | 247,611 | Jul 11, 2024 |
| Congleton Jon | Chief Executive Officer | Sale | 15,746 | $13.34 | $210,052 | 911,212 | Jul 11, 2024 |
| Congleton Jon | Chief Executive Officer | Sale | 14,940 | $11.73 | $175,246 | 926,958 | Jun 18, 2024 |
| Congleton Jon | Chief Executive Officer | Sale | 16,229 | $12.52 | $203,187 | 976,271 | Jun 13, 2024 |
| Levy Adam Scott | CFO and Secretary | Sale | 96,815 | $12.94 | $1,252,786 | 255,462 | Jun 11, 2024 |
| Rodman David Malcom | Chief Medical Officer | Option Exercise | 6,349 | $1.08 | $6,857 | 89,729 | Jun 11, 2024 |